DCM Shriram Limited (DCMSHRIRAM) Q2 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

DCM Shriram is a diversified conglomerate spanning chemicals and vinyl, sugar and ethanol, Fenesta building systems, and agri-inputs, and its Q2 FY 2026-2027 print arrives with the West Asia conflict keeping energy and freight costs elevated through the quarter. The results will speak to whether chemicals margins hold against firm power costs and soft chlorine realisations, and how much the reinstated PVC import duty plus the US$766/MT minimum import price revives the Vinyl segment after Q1's 25% PVC volume drop.

DCM Shriram Limited Q2 Results Date and Time

The board will meet on 26 October 2026 to consider the Q2/H1 FY27 audited financial results and interim dividend consideration, with a record date of 30 October 2026. The trading window remained closed from 1 to 28 October 2026.

What to expect from DCM Shriram Limited's Q2 FY27 results

The quarter's story is a group-level margin test against firm energy costs, partially offset by a full quarter of PVC import protection. Brent averaged high through the quarter — crossing $105/bbl on 10 September, briefly touching $110 in October, and sitting at $107.57 on 19 October — while September's WPI inflation quickened to 11.39% on fuel and food costs, and Q1 power and fuel costs already grew 10.8% YoY against 9.5% revenue growth. Chemicals remains the growth engine with caustic utilization at 82% in Q1 FY27 and ECU prices up 7% YoY, though chlorine stays negative at minus Rs. 7,000 to minus Rs. 8,000 and Chinese oversupply caps realization upside. The Vinyl segment is set up for a recovery off Q1's depressed base given the DGFT restriction dated 24 July 2026 spans the entire quarter, while the monsoon stayed deficient all season (below 90% of LPA) and management has already guided that the Bioseed Q2 recovery will 'not be substantial'. Clean earnings will again be the honest base: Q1 reported PAT of Rs. 693.44 Cr was flattered by a Rs. 474.3 Cr tax adjustment and Rs. 79.4 Cr of exceptional items versus a normal PAT of Rs. 147 Cr, so Q2 will be judged on the normalized run-rate.

Key Things To Watch

Guidance scorecard to interrogate: Management's stated FY27 commitments and where each stands heading into the call.

• Group capex of INR 1,000–1,200 crore for FY27 — check H1 FY27 actual deployment
• Net borrowing: broadly similar levels with ~INR 200-odd crore reduction by end FY27 — check net debt vs Rs. 1,649 Cr at Jun-26 and the sugar-season inventory impact
• Debt/EBITDA cap of 1.5 — currently ~1.1
• Formulated resin capacity 14,000 to 50,000 TPA (capex INR 101 crore) by Q2 FY28 — early-stage check
• Epoxy (HSCL) break-even 'this year' (FY27) and healthy Advanced Materials profitability FY27 onwards — track H1 FY27 EBITDA trend of HSCL
• Fenesta ~14% normalized EBITDA margin — track vs Q1 FY27 PBDIT margin of ~13% (40/303)
• Demerger: applications to be filed within FY27; structure finalization was targeted 3–4 months from the Q3 FY26 call — status update needed
• Salt works acquisition (2.1 lakh MTPA, ~INR 175 crore) — Q1 FY27 target — completion not confirmed in retrieved sources
• Caustic utilization 'robust' in FY27 — vs 82% in Q1 FY27

Operational follow-ups

• CaCl2 line 2 (133 TPD) commissioning in Oct 2026 and ramp-up of the AlCl3/CaCl2 lines commissioned 30 Sep 2026
• Bioseed Q2 recovery — management explicitly guided that recovery would 'not be substantial'; assess actual monsoon damage
• PVC: effect of reinstated BCD and US$766/MT MIP on volumes and realizations after Q1's 25% PVC volume drop
• ECH/epoxy utilization (~70%) and whether ECH stabilization issues flagged in Q3 FY26 are fully resolved
• Normalized earnings base: Q1 FY27 reported PAT was flattered ~4.7x vs the Rs. 147 Cr normal PAT — establish the clean run-rate for H1
• Tax guidance: effective tax outflow of 19% for the next 5–10 years vs 25% reflected in P&L — implications for cash flow and EPS
• Ethanol: optimization of grain-based ethanol up to 260 KLD based on margins; OMC allocation and export-levy litigation
• Interim dividend decision at the 26 Oct 2026 board meeting (record date 30 Oct 2026)

Chemicals margin bridge and energy costs: From the operating-metric recap and quarter drivers.

• Q2 ECU realization vs 'just below INR30,000' and chlorine at minus INR7,000 to minus INR8,000; utilization vs 82% in Q1 FY27
• Quantified energy-cost pass-through after Q1 power and fuel costs grew 10.8% YoY against 9.5% revenue growth
• Ramp status of the AlCl3 (total 250 TPD) and CaCl2 lines commissioned 30 Sep 2026 at Jhagadia, Bharuch

Risks and headwinds to monitor: Management-flagged risks material to this quarter.

• West Asia conflict impacting supply chains, energy and freight markets; rising energy prices pose a margin risk if not passed through
• Excess Chinese capacity continuing to weigh on international chemical pricing across major value chains
• Deficient southwest monsoon (below 90% of LPA) with Bioseed sowing down 15–20% in key regions and 'a significant portion of the business being lost'
• Sugar margins expected lower pending government support on MSP, exports, or ethanol policy; OMC allocation for sugarcane-based ethanol cut to 28% from 34%